Table 2 Correlation between the clinicopathologic characteristics and expression of HDGF protein in glioma
Characteristics | n | ENO1 (%) | P | |
|---|---|---|---|---|
High-expression | Low-expression | |||
Gender | ||||
Male | 88 | 63 (71.6%) | 25 (28.4%) | |
Female | 48 | 31 (64.6%) | 17 (35.4%) | 0.398 |
Age | ||||
≥50 | 73 | 50 (68.5%) | 23 (31.5%) | |
<50 | 63 | 44 (69.8%) | 19 (30.2%) | 0.865 |
Histologic type | ||||
Astrocytic tumors | 98 | 67 (68.4%) | 31 (31.6%) | |
Oligodendrogial tumors | 15 | 14 (93.3%) | 1 (6.7%) | |
Oligoastrocytic tumors | 23 | 13 (56.5%) | 10 (43.5%) | 0.053 |
WHO grade | ||||
I + II | 41 | 18 (43.9%) | 23 (56.1%) | |
III + IV | 95 | 76 (80.0%) | 19 (20.0%) | 0.000 |